@article{cf25785d44d244d2bdd894d21458b659,
title = "Serine 62-phosphorylated MYC Associates with nuclear lamins and its regulation by CIP2A is essential for regenerative proliferation",
abstract = "An understanding of the mechanisms determining MYC's transcriptional and proliferation-promoting activities in vivo could facilitate approaches for MYC targeting. However, post-translational mechanisms that control MYC function in vivo are poorly understood. Here, we demonstrate that MYC phosphorylation at serine 62 enhancesMYC accumulation on Lamin A/C-associated nuclear structures and that the protein phosphatase 2A (PP2A) inhibitor protein CIP2A is required for this process. CIP2A is also critical for serum-induced MYC phosphorylation and for MYC-elicited proliferation induction in vitro. Complementary transgenic approaches and an intestinal regeneration model further demonstrated the in vivo importance of CIP2A and serine 62 phosphorylation forMYCactivity upon DNA damage. However, targeting of CIP2A did not influence the normal function of intestinal crypt cells. These data underline the importance of nuclear organization in the regulation of MYC phosphorylation, leading to an in vivo demonstration of a strategy for inhibiting MYC activity without detrimental physiological effects.",
author = "Kevin Myant and Xi Qiao and Tuuli Halonen and Christophe Come and Anni Laine and Mahnaz Janghorban and Partanen, {Johanna I.} and John Cassidy and Ogg, {Erinn Lee} and Patrizia Cammareri and Tiina Laiter{\"a} and Juha Okkeri and Juha Klefstr{\"o}m and Sears, {Rosalie C.} and Sansom, {Owen J.} and Jukka Westermarck",
note = "Funding Information: We thank Prof. Martin Eilers, Prof. Johanna Ivaska, Dr. Pekka Taimen, and Dr. Daniel Abankwa for critical reading of the manuscript and Prof. Bruno Amati for his valuable advice regarding ChIP analysis. Taina Kalevo-Mattila is thanked for technical help and Jouko Sandstr{\"o}m and Markku Saari at the Turku Centre for Biotechnology Cell Imaging Core facility for help with imaging. This study was supported by funding from the Association of International Cancer Research (grants 08-0614 and 10-0643), the Academy of Finland (grants 122546, 137687, and 267817), Finnish Cancer Organisations, the Foundation of Finnish Cancer Institute, the Sigrid Juselius Foundation, the NIH (grants R01 CA129040 and R01 CA100855), The European Research Council (Coloncan), European Commission FP7-Health (grant 278568), and Cancer Research UK (grant A12481). Publisher Copyright: {\textcopyright} 2015 The Authors.",
year = "2015",
doi = "10.1016/j.celrep.2015.07.003",
language = "English (US)",
volume = "12",
pages = "1019--1031",
journal = "Cell Reports",
issn = "2211-1247",
publisher = "Cell Press",
number = "6",
}